Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACONWOTCMKTS:BNVIFOTCMKTS:DOCRFOTCMKTS:SSYNF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACONWAclarion$0.03-20.0%$0.04$0.01▼$0.24N/AN/A42,428 shs27,256 shsBNVIFBinovi Technologies$0.00$0.00▼$0.00N/AN/A2,279 shsN/ADOCRFCloudMD Software & Services$0.03-2.9%$0.03$0.02▼$0.13N/AN/A42,868 shs50,400 shsSSYNFArcturis Data$0.00$0.00$0.00▼$0.00N/AN/A136,467 shsN/A12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACONWAclarion-11.85%+5.61%+9.97%-45.67%-20.00%BNVIFBinovi Technologies0.00%0.00%0.00%0.00%0.00%DOCRFCloudMD Software & Services0.00%0.00%0.00%0.00%+7.20%SSYNFArcturis Data0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACONWAclarionN/AN/AN/AN/AN/AN/AN/AN/ABNVIFBinovi TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ADOCRFCloudMD Software & ServicesN/AN/AN/AN/AN/AN/AN/AN/ASSYNFArcturis DataN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACONWAclarion 0.00N/AN/AN/ABNVIFBinovi Technologies 0.00N/AN/AN/ADOCRFCloudMD Software & Services 0.00N/AN/AN/ASSYNFArcturis Data 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACONWAclarion$54.60KN/AN/AN/AN/AN/ABNVIFBinovi TechnologiesN/AN/AN/AN/AN/AN/ADOCRFCloudMD Software & ServicesN/AN/AN/AN/AN/AN/ASSYNFArcturis DataN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACONWAclarionN/AN/A0.00∞N/AN/AN/AN/AN/ABNVIFBinovi TechnologiesN/AN/A0.00N/AN/AN/AN/AN/AN/ADOCRFCloudMD Software & ServicesN/AN/A0.00∞N/AN/AN/AN/AN/ASSYNFArcturis DataN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACONWAclarionN/AN/AN/AN/AN/ABNVIFBinovi TechnologiesN/AN/AN/AN/AN/ADOCRFCloudMD Software & ServicesN/AN/AN/AN/AN/ASSYNFArcturis DataN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACONWAclarionN/ABNVIFBinovi TechnologiesN/ADOCRFCloudMD Software & ServicesN/ASSYNFArcturis DataN/AInsider OwnershipCompanyInsider OwnershipACONWAclarionN/ABNVIFBinovi TechnologiesN/ADOCRFCloudMD Software & ServicesN/ASSYNFArcturis DataN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACONWAclarion7N/AN/ANot OptionableBNVIFBinovi TechnologiesN/AN/AN/ANot OptionableDOCRFCloudMD Software & ServicesN/AN/AN/ANot OptionableSSYNFArcturis Data158N/AN/ANot OptionableDOCRF, ACONW, SSYNF, and BNVIF HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimeDOCRF, ACONW, SSYNF, and BNVIF Company DescriptionsAclarion NASDAQ:ACONW$0.03 -0.01 (-20.00%) As of 06/12/2025 03:12 PM EasternAclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.Binovi Technologies OTCMKTS:BNVIFBinovi Technologies Corp. engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company's products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company's products under development includes Binovi Connect, a web-based video conferencing solution that connects consumers to vision care professionals. The company was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020. Binovi Technologies Corp. is based in Vancouver, Canada.CloudMD Software & Services OTCMKTS:DOCRF$0.03 0.00 (-2.90%) As of 07/10/2024CloudMD Software & Services Inc. offers healthcare services in Canada and the United States. It operates in two segments, Health and Productivity Solutions and Health and Wellness Services. The Health and Productivity Solutions segment provides health and productivity tools, including remote patient monitoring that allows clinics, health systems, benefit plans, and employers to track vital statistics of its patients, members, and employees; MyHealthAccess, a patient portal for online appointment booking and virtual care visits; health and wellness network solutions that focuses on enabling healthcare providers to be in constant connection with their patients and enables patients to be cared for digitally, remotely, and holistically; real time intervention platform that enables an automated real time inquiry of disparate data sources across multiple domains, and identifies indicators and compute risk scores; and medical reference library, a health educational platform that provides peer-reviewed resources for healthcare professionals. The Health and Wellness Services segment offers organizations with an employee and family assistance program; mental health care, such as coaching, therapy, and treatment for chronic conditions; health coaching; medical assessments; and occupational health and absence management services through the company's integrated connected platform Kii. This segment also provides virtual care and rehabilitation and assessments. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. CloudMD Software & Services Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.Arcturis Data OTCMKTS:SSYNF$0.0002 0.00 (0.00%) As of 04/29/2024Arcturis Data Limited, a data company, uses data to support the discovery and development of new medicines. It supports the delivery of research across various phases of the clinical development pipeline covering various conditions and treatment types. The company translates patient pathways to support clinical development, inform policy, and advance research. It collaborates with research and industry experts to create disease-specific datasets. The company was formerly known as Sensyne Health Limited and changed its name to Arcturis Data Limited in October 2022. Arcturis Data Limited was incorporated in 2018 and is based in Kidlington, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ignore the Noise—Samsara Stock Is Still a Strong Buy Oracle’s Cloud Boom Is Just Getting Started Netflix Sets New Highs—Price Targets Keep Climbing IonQ’s $1B Acquisition and Drug Discovery Leap With NVIDIA Alibaba’s Dip Is a Gift—Here’s the Price That Matters Betting on Disruption: Is Lemonade the Future of Insurance? Starbucks Stock: Culture Fix May Be Key to Long-Term Growth GameStop Turns a Profit, But Core Business Keeps Shrinking Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
